A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.

ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.